Center for Research on Complex Generics (U18) Clinical Trials Optional

The Food and Drug Administration (FDA) is seeking to fund a Center for Research on Complex Generics under a cooperative agreement. The center's goals include facilitating engagement with generic industry representatives, providing a forum for experts to collaborate on research, coordinating and conducting research projects, hosting scientific workshops, and providing public access to generic drug research outcomes. The center is expected to complement FDA's existing regulatory science programs and enhance collaborations with the generic drug industry. Some key aspects of this opportunity include: • Facilitating engagement with generic industry representatives to identify scientific challenges for generic product development or assessment • Providing a forum for experts from FDA, academia, the generic drug industry, and elsewhere to collaborate on research related to generic products • Coordinating and conducting research projects pertaining to generic products, particularly complex generics • Hosting scientific workshops, providing training, and supporting other educational activities pertaining to generic drug research • Providing free and open public access to generic drug research outcomes such as scientific articles, posters, presentations, and other resources